Orchestra BioMed
$4.85
5
+$0.11+2.32% 13:32 Today
Statistics
Day High
4.85
Day Low
4.85
52W High
5.78
52W Low
2.2
Volume
10
Avg. Volume
-
Mkt Cap
291.51M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
16NovExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.5
-0.44
-0.39
-0.33
Expected EPS
-0.407143
Actual EPS
N/A
Financials
-158.16%Profit Margin
Unprofitable33.48MRevenue
-52.96MNet Income
Analyst Ratings
13.25Average Price Target
The highest estimate is 20.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap194.62B
Medtronic
MDT
Mkt Cap116.77B
Boston Scientific
BSX
Mkt Cap67.88B
Edwards Lifesciences
EW
Mkt Cap52B
Stryker
SYK
Mkt Cap126.84B
Zimmer Biomet
ZBH
Mkt Cap19.25B
Intuitive Surgical
ISRG
Mkt Cap131.63B
Baxter International
BAX
Mkt Cap13.51B
Johnson & Johnson
JNJ
Mkt Cap645.95B
About
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
Show more...
CEO
David Hochman
Employees
86
Country
United States
ISIN
US68572M1062
Listings
0 Comments
Share your thoughts
FAQ
What is Orchestra BioMed stock price today?▼
The current price of OBIO is $4.85 USD — it has increased by +2.32% in the past 24 hours. Watch Orchestra BioMed stock price performance more closely on the chart.
What is Orchestra BioMed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Orchestra BioMed stocks are traded under the ticker OBIO.
Is Orchestra BioMed stock price growing?▼
OBIO stock has fallen by -8.58% compared to the previous week, the month change is a +11.01% rise, over the last year Orchestra BioMed has showed a +72.99% increase.
What is Orchestra BioMed market cap?▼
Today Orchestra BioMed has the market capitalization of 291.51M
When is the next Orchestra BioMed earnings date?▼
Orchestra BioMed is going to release the next earnings report on November 16, 2026.
What were Orchestra BioMed earnings last quarter?▼
OBIO earnings for the last quarter are -0.38 USD per share, whereas the estimation was -0.39 USD resulting in a +3.06% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Orchestra BioMed revenue for the last year?▼
Orchestra BioMed revenue for the last year amounts to 33.48M USD.
What is Orchestra BioMed net income for the last year?▼
OBIO net income for the last year is -52.96M USD.
How many employees does Orchestra BioMed have?▼
As of September 04, 2026, the company has 86 employees.
In which sector is Orchestra BioMed located?▼
Orchestra BioMed operates in the Health & Wellness sector.
When did Orchestra BioMed complete a stock split?▼
Orchestra BioMed has not had any recent stock splits.
Where is Orchestra BioMed headquartered?▼
Orchestra BioMed is headquartered in NEW HOPE, United States.